NCT07760311Not yet recruiting
Feasibility Study to Evaluate a Digital Tool for Monitoring Patients Who Have Discontinued Treatment for Chronic Myeloid Leukemia
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
The objective of this project is to evaluate, over a 12-month period, the feasibility of integrating a digital tool into the follow-up care of patients with chronic myeloid leukemia who have been off treatment for up to 2 years. Feasibility will be assessed based on the usage rate, defined as the proportion of patients who accessed the digital tool at least: * once a month, if treatment discontinuation was ≤ 6 months; * once a quarter, if treatment discontinuation was \> 6 months. The usage rate will be assessed and compared to a threshold of 60%; if the rate falls below this threshold, feasibility will be considered insufficient.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 7 Aug 2026
- Start date
- 15 Sept 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Versailles Hospital
- Diseases
- Chronic myeloid leukaemia
- NCT number
- NCT07760311
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 15 Sept 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Patients who cannot read or understand French;
- Individuals entitled to enhanced protection, namely minors, individuals deprived of their liberty by a judicial or administrative decision, individuals staying in a health or social care facility, adults under legal guardianship, and, finally, patients in emergency situations
Who the study is looking for
- Patients aged 18 or older
- Patients with chronic myeloid leukemia who have been off treatment for ≤ 2 years
- Patients with access to a digital device with internet access
- Be enrolled in the social security system
- Have given verbal consent after reviewing the study information sheet
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| CH de Versailles Coordinator of this site? Confirm its status | Le Chesnay | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.